Andlauer Healthcare Group Inc.
AND.TO · TSX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | CA$1 | CA$1 | CA$1 | CA$0 |
| % Growth | 0.4% | -0.1% | 47.3% | – |
| Cost of Goods Sold | CA$1 | CA$1 | CA$0 | CA$0 |
| Gross Profit | CA$0 | CA$0 | CA$0 | CA$0 |
| % Margin | 22.6% | 22.8% | 24.5% | 25.2% |
| R&D Expenses | CA$0 | CA$0 | CA$0 | CA$0 |
| G&A Expenses | CA$0 | CA$0 | CA$0 | CA$0 |
| SG&A Expenses | CA$0 | CA$0 | CA$0 | CA$0 |
| Sales & Mktg Exp. | CA$0 | CA$0 | CA$0 | CA$0 |
| Other Operating Expenses | CA$0 | CA$0 | -CA$0 | CA$0 |
| Operating Expenses | CA$0 | CA$0 | CA$0 | CA$0 |
| Operating Income | CA$0 | CA$0 | CA$0 | CA$0 |
| % Margin | 14.4% | 14.8% | 17% | 16.7% |
| Other Income/Exp. Net | -CA$0 | -CA$0 | -CA$0 | CA$0 |
| Pre-Tax Income | CA$0 | CA$0 | CA$0 | CA$0 |
| Tax Expense | CA$0 | CA$0 | CA$0 | CA$0 |
| Net Income | CA$0 | CA$0 | CA$0 | CA$0 |
| % Margin | 9.9% | 10.2% | 11.8% | 20.4% |
| EPS | 1.6 | 1.58 | 1.82 | 2.3 |
| % Growth | 1.3% | -13.2% | -20.9% | – |
| EPS Diluted | 1.58 | 1.55 | 1.79 | 2.25 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | CA$0 | CA$0 | CA$0 | CA$0 |
| Interest Expense | CA$0 | CA$0 | CA$0 | CA$0 |
| Depreciation & Amortization | CA$0 | CA$0 | CA$0 | CA$0 |
| EBITDA | CA$0 | CA$0 | CA$0 | CA$0 |
| % Margin | 25.6% | 25.8% | 27% | 35.8% |